LIQUIDCASE vs PHARMABEES: Stock Comparison
Head-to-head financial and trading comparison between LIQUIDCASE (LIQUIDCASE) and PHARMABEES (PHARMABEES) in the Cross-Sector Peers sector.
LIQUIDCASE
NSE: LIQUIDCASEPHARMABEES
NSE: PHARMABEESKey Metrics Comparison Table
| Metric | LIQUIDCASE | PHARMABEES | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹116.32 | ₹26.72 | — |
| 1-Year Price Return | +2.32% | +16.07% | PHARMABEES (13.75% higher) |
| 52-Week High | ₹116.32 | ₹27.89 | — |
| 52-Week Low | ₹113.68 | ₹23.00 | — |
| 30-Day Annualized Volatility | 0.23% | 14.23% | LIQUIDCASE (Steadier) |
| 30-Day Average Daily Volume | 20,112,480 | 4,400,662 | LIQUIDCASE (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between LIQUIDCASE and PHARMABEES, which stock gave better returns over the last year?
PHARMABEES has outperformed LIQUIDCASE over the past 12 months with a gain of 16.07% compared to 2.32%.
Which stock is less volatile: LIQUIDCASE or PHARMABEES?
LIQUIDCASE demonstrated lower price volatility (0.23% annualized) compared to PHARMABEES (14.23%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of LIQUIDCASE vs PHARMABEES?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are LIQUIDCASE and PHARMABEES direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.